Skip to content

Upjohn

Active
Private limited companyfounded 201412 yrs activeTerhulpsesteenweg 6A, 1560 Hoeilaart, BelgiumKBO/BCE: BE 0552.558.025
Summary

Upjohn has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €12.1m and a net result of €850,025. Equity is shrinking by ~10% per year across the filed fiscal years. Its solvency ranks better than 95% of 65 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability55▲+1
Solvency100=
Growth22=
Track record100
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €850,000 at 30 days acceptable
Liquidity ample (current ratio 48.99 against 24.98 in 2024; short-term debt: 2% and cash: 0% of total assets), and 2% of the assets are financed with debt.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
98%
Return on assets
6.9%
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 21
Relative position
BE, all sectors
reference
Manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21)
about 14% more bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 12 years 0 20 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
24 d early
2024
34 d early
2023
34 d early
2022
3 d late
2021
21 d early
2020
27 d early
2019
1 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 20 days before the deadline; the sector median for financial year 2024 is 9 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
27-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

Upjohn was incorporated on 9 May 2014.1 Revenue fell from EUR 113 million in 2018 to EUR 4,772 in 2023 and headcount from 34.1 full-time equivalents in 2018 to 4.4 in 2022.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018, 2022 and 2023

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

Turnover
€4,772▼ 100.0%
2022 · €23.5m
EBIT margin
16513.5%▲ 16509.0pp
2022 · 4.5%
Net result
€850,025▲ 8.8%
2024 · €781,099
Working capital
€12.1m▲ 7.6%
2024 · €11.2m
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20192022202320242025
Turnover€60.0m▼ 46.8%€23.5m-€4,772▼ 100.0%
Operating result€2.8m▼ 2.8%€1.0m-€788,090▼ 24.9%€730,218▼ 7.3%€920,506▲ 26.1%
Net result€2.5m▼ 14.4%€773,409-€889,297▲ 15.0%€781,099▼ 12.2%€850,025▲ 8.8%
EBIT margin4.7%▲ 2.1pp4.5%-16513.5%▲ 16509.0pp
Equity€13.0m▼ 80.8%€16.6m-€10.5m▼ 36.9%€11.2m▲ 7.5%€12.1m▲ 7.6%
Total assets€25.0m▼ 73.1%€25.1m-€11.1m▼ 55.9%€11.7m▲ 5.6%€12.3m▲ 5.4%
Debt€12.0m▼ 52.7%€8.6m-€628,921▼ 92.7%€468,927▼ 25.4%€252,075▼ 46.2%
Working capital€13.7m▼ 78.9%€16.6m-€10.5m▼ 36.9%€11.2m▲ 7.5%€12.1m▲ 7.6%
Staff (FTE)21.2▼ 37.8%4.4-
Why a figure moved sharply
  • 2023 Turnover -100% on 2022. The previous fiscal year ran 13 months, this one 12.
Result per fiscal year
Operating resultNet result
€0€1.0m€2.0m€3.0mOperating result 2019: €2.8m€2.8mNet result 2019: €2.5m€2.5mOperating result 2022: €1.0m€1.0mNet result 2022: €773,409€773,409Operating result 2023: €788,090€788,090Net result 2023: €889,297€889,297Operating result 2024: €730,218€730,218Net result 2024: €781,099€781,099Operating result 2025: €920,506€920,506Net result 2025: €850,025€850,02520192022202320242025€0€250,000€500,000€750,000€1mOperating result 2023: €788,090€788,000Net result 2023: €889,297€889,000Operating result 2024: €730,218€730,000Net result 2024: €781,099€781,000Operating result 2025: €920,506€921,000Net result 2025: €850,025€850,000202320242025
The operating result recovers in 2025; 2025 is 26% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €12.3m
Equity €12.1m ▲ 7.6%
Debt €252,075 ▼ 46.2%
Debt's share of the balance-sheet total falls from 4.0% to 2.0%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
Current ratio
48.99▲
2024 · 24.98
Debt to equity
0.02▼
2024 · 0.04
ROE
7.0%▲
2024 · 6.9%
ROA
6.9%▲
2024 · 6.7%
Debt ≤ 1 year
€252,075▼
2024 · €468,927
Income taxes
€306,346▲
2024 · €303,323
Staff costs
-€5,760▼
2024 · €1,756
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 545 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 95% are still going.

  • Medium-sized
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.2% went bankrupt
4.2% stopped otherwise
95% still going

A further 0.6% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.4% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.6%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 545 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 46 lines
Balance sheet Code20242025
Assets
Total assets20/58€11.7m€12.3m▲
Fixed assets21/28€0€0=
Intangible fixed assets21€0€0=
Current assets29/58€11.7m€12.3m▲
Amounts receivable within one year40/41€11.5m€12.3m▲
Trade receivables40€557,664€319,490▼
Other amounts receivable41€11.0m€12.0m▲
Cash at bank and in hand54/58€171,622€0▼
Equity and liabilities
Total equity and liabilities10/49€11.7m€12.3m▲
Equity10/15€11.2m€12.1m▲
Contributions10/11€6.4m€6.4m=
Reserves13€1.3m€1.3m=
Non-distributable reserves130/1€3,811€3,811=
Other1319€3,811€3,811=
Tax-exempt reserves132€625,603€625,603=
Distributable reserves133€627,735€627,735=
Profit (loss) carried forward14€3.6m€4.4m▲
Amounts payable17/49€468,927€252,075▼
Amounts payable within one year42/48€468,927€252,075▼
Trade debts44€252,963€175,626▼
Suppliers440/4€252,963€175,626▼
Taxes, remuneration and social security45€7,508€69,008▲
Taxes450/3€5,323€69,008▲
Remuneration and social security454/9€2,184€0▼
Other amounts payable47/48€208,457€7,441▼
Income statement Code20242025
Operating income70/76A€815,543€944,124▲
Other operating income74€815,543€944,124▲
Operating charges60/66A€85,325€23,618▼
Services and other goods61€79,938€29,379▼
Remuneration, social security and pensions62€1,756-€5,760▼
Other operating charges640/8€3,631€0▼
Operating profit (loss)9901€730,218€920,506▲
Financial income75/76B€360,448€244,311▼
Recurring financial income75€360,448€244,311▼
Income from current assets751€2,849€11,728▲
Other financial income752/9€357,599€232,583▼
Financial charges65/66B€6,244€8,446▲
Recurring financial charges65€6,244€8,446▲
Other financial charges652/9€6,244€8,446▲
Profit (loss) for the period before taxes9903€1.1m€1.2m▲
Income taxes67/77€303,323€306,346▲
Taxes670/3€303,323€306,346▲
Profit (loss) for the period9904€781,099€850,025▲
Profit (loss) for the period to be appropriated9905€781,099€850,025▲
Appropriation of the result
Profit (loss) to be appropriated9906€3.6m€4.4m▲
Profit (loss) brought forward from the previous period14P€2.8m€3.6m▲

The notes to these accounts (21 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20192022202320242025Change
Operating income70/76A€60.8m€30.3m€973,537€815,543€944,124▲ 15.8%
Turnover70€60.0m€23.5m€4,772---
Other operating income74€810,691€6.8m€968,764€815,543€944,124▲ 15.8%
Operating charges60/66A€58.0m€29.2m€185,447€85,325€23,618▼ 72.3%
Goods for resale, raw materials and consumables60€42.3m€20.1m----
Purchases600/8-€10.3m----
Change in stocks: decrease (increase)609€4.1m€9.9m----
Services and other goods61€7.9m€1.4m€140,223€79,938€29,379▼ 63.2%
Remuneration, social security and pensions62€3.2m€1.5m€17,379€1,756-€5,760▼ 428%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1.3m-----
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€1.0m-€792,758----
Provisions for liabilities and charges: additions (uses and reversals)635/8-€65,313-----
Other operating charges640/8€4.4m€7.1m€27,844€3,631€0▼ 100%
Operating profit (loss)9901€2.8m€1.0m€788,090€730,218€920,506▲ 26.1%
Financial income75/76B-€22,487€412,270€360,448€244,311▼ 32.2%
Recurring financial income75€430,409€22,483€412,270€360,448€244,311▼ 32.2%
Income from current assets751€3-€405,551€2,849€11,728▲ 312%
Other financial income752/9€430,406€22,483€6,719€357,599€232,583▼ 35.0%
Non-recurring financial income76B-€4----
Financial charges65/66B€446,220€40,794€8,135€6,244€8,446▲ 35.3%
Recurring financial charges65€446,220€40,794€8,135€6,244€8,446▲ 35.3%
Debt charges650€500€18,779----
Other financial charges652/9€445,720€22,015€8,135€6,244€8,446▲ 35.3%
Profit (loss) for the period before taxes9903€2.8m€1.0m€1.2m€1.1m€1.2m▲ 6.6%
Income taxes67/77€335,611€257,803€302,928€303,323€306,346▲ 1.0%
Taxes670/3€335,611€257,803€302,928€303,323€306,346▲ 1.0%
Profit (loss) for the period9904€2.5m€773,409€889,297€781,099€850,025▲ 8.8%
Profit (loss) for the period to be appropriated9905€2.5m€773,409€889,297€781,099€850,025▲ 8.8%
Line20192022202320242025Change
Assets
Total assets20/58€25.0m€25.1m€11.1m€11.7m€12.3m▲ 5.4%
Fixed assets21/28€177,636€0€0€0€0-
Intangible fixed assets21-€0€0€0€0-
Financial fixed assets28€177,636-----
Other financial fixed assets284/8€177,636-----
Amounts receivable and cash guarantees285/8€177,636-----
Current assets29/58€24.8m€25.1m€11.1m€11.7m€12.3m▲ 5.4%
Stocks and contracts in progress3€7.3m-----
Stocks30/36€7.3m-----
Goods purchased for resale34€7.3m-----
Amounts receivable within one year40/41€4.7m€24.0m€10.9m€11.5m€12.3m▲ 7.0%
Trade receivables40€4.0m€587,255€181,217€557,664€319,490▼ 42.7%
Other amounts receivable41€691,545€23.4m€10.7m€11.0m€12.0m▲ 9.5%
Cash at bank and in hand54/58€12.4m€1.2m€172,278€171,622€0▼ 100%
Deferred charges and accrued income490/1€405,702-----
Equity and liabilities
Total equity and liabilities10/49€25.0m€25.1m€11.1m€11.7m€12.3m▲ 5.4%
Equity10/15€13.0m€16.6m€10.5m€11.2m€12.1m▲ 7.6%
Contributions10/11€6.3m€6.4m€6.4m€6.4m€6.4m=
Capital10€6.3m-----
Issued capital100€6.3m-----
Outside capital11€174,543-----
Reserves13€1.3m€1.3m€1.3m€1.3m€1.3m=
Non-distributable reserves130/1-€3,811€3,811€3,811€3,811=
Legal reserve130€625,291-----
Reserves not available under the articles1311€3,811-----
Other1319-€3,811€3,811€3,811€3,811=
Tax-exempt reserves132€625,603€625,603€625,603€625,603€625,603=
Distributable reserves133€2,444€627,735€627,735€627,735€627,735=
Profit (loss) carried forward14€5.3m€8.9m€2.8m€3.6m€4.4m▲ 23.9%
Amounts payable17/49€12.0m€8.6m€628,921€468,927€252,075▼ 46.2%
Amounts payable within one year42/48€11.1m€8.6m€628,921€468,927€252,075▼ 46.2%
Trade debts44€7.6m€1.3m€266,634€252,963€175,626▼ 30.6%
Suppliers440/4€7.6m€1.3m€266,634€252,963€175,626▼ 30.6%
Taxes, remuneration and social security45€3.5m€122,140€128,278€7,508€69,008▲ 819%
Taxes450/3€2.7m€118,171€91,921€5,323€69,008▲ 1,196%
Remuneration and social security454/9€788,500€3,970€36,357€2,184€0▼ 100%
Other amounts payable47/48-€7.2m€234,009€208,457€7,441▼ 96.4%
Accrued charges and deferred income492/3€924,283€0----
Line20192022202320242025Change
Profit (loss) for the period9904€2.5m€773,409€889,297€781,099€850,025▲ 8.8%
+ Depreciation and write-downs630€1.3m-----
Operating cash flow (approximation)€3.7m€773,409€889,297€781,099€850,025▲ 8.8%
Investment in fixed assets (approximation)--€0€0€0-
Change in cash---€1.0m-€656-€171,622▼ 26,050%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
07-07
NBB filing Annual accounts filed
fiscal year 2025 · full schema
2025
27-06
NBB filing Annual accounts filed
fiscal year 2024 · full schema
2024
27-06
NBB filing Annual accounts filed
fiscal year 2023 · unclassified schema
2023
31-12
Financial Liquidity times 6current ratio 17.64
Current ratio from 2.94 to 17.64; short-term debt falls from €8.6m to €628,921.
03-08
NBB filing Annual accounts filed
fiscal year 2022 · unclassified schema · 3 days late
2022
31-12
Financial Weakest financial yearnet €773,409 ▼68.7%
Net result drops to €773,409, the lowest in the series; recovery starts the following year.
09-06
NBB filing Annual accounts filed
fiscal year 2021 · unclassified schema
2021
03-06
NBB filing Annual accounts filed
fiscal year 2020 · unclassified schema
2020
29-06
NBB filing Annual accounts filed
fiscal year 2019 · full schema
2019
22-05
NBB filing Annual accounts filed
fiscal year 2018 · full schema
22-01
State Gazette act Merger · Accounting effect
Board meeting · Corporate purpose
2018
30-05
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
09-06
NBB filing Annual accounts filed
fiscal year 2016 · full schema
2014
27-10
State Gazette act Demerger · Accounting effect
Share issue · Power of attorney
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 34 acts read
About the unread acts

We know of 34 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
34 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hoeilaart · 1 establishment unit since 2021
seat establishment approximate The establishment unit on the map
Ground area
5,791 m²
Building footprint
1,094 m²
Volume, LiDAR
11,847 m³
2 parcels, Flanders · tallest building 15.2 m, ±4 floors. Linked by address, not a title deed.
6 companies at this address See who is registered here
1 establishment unit
Upjohn
Terhulpsesteenweg 6, 1560 HoeilaartWholesale of pharmaceutical and medical goods
since 20212.316.985.253
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23033C0075/00L019 Flanders 3,821 m² 1 · 921 m² 14.7 m · 4 fl.
23033C0073/00E009 Flanders 1,970 m² 1 · 173 m² 15.2 m · 2 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Part of the group PFIZER INC. 6 companies Group, risk and exposure

Owners and holdings

1 owner · 1 holding

Chain of control

  1. PFIZER INC.US ultimately, LEI
  2. Upjohn

Highest known parent: PFIZER INC. (United States). The sources do not say who stands above it.

Owners 1

Holdings 1

According to the 2025 annual accounts of Upjohn and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Acquisitions and mergers

1 transaction
Received in a demerger part of:Pfizer
BE 0401.994.823proposal · State Gazette act of 27-10-2014

Recognitions · licences · registrations

Legal Entity Identifier

549300UA90IW9N6RHU66
no longer live in the LEI register

Similar companies · same sector, comparable size

Of 148 companies in sector 21201 we hold annual accounts for 116. 61 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded09-05-2014
Fiscal year end31-12
Activities, NACEBEL 2025
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
46460Wholesale of pharmaceutical and medical goods
E-invoicing
Reachable via Peppol
Peppol ID 0208:0552558025
Also 9925:BE0552558025
Registered 16-12-2025

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.